The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 14, 2026

Filed:

Sep. 30, 2020
Applicant:

Maxwell Biosciences, Inc., Austin, TX (US);

Inventors:

Annelise E. Barron, Woodside, CA (US);

Joshua Mcclure, West Lake Hills, TX (US);

Gill Diamond, Prospect, KY (US);

Natalia Molchanova, Kobenhavn V, DK;

Assignee:

Maxwell Biosciences, Inc., Austin, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/10 (2006.01); A61K 38/05 (2006.01); A61K 38/06 (2006.01); A61K 38/07 (2006.01); A61K 38/08 (2019.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01);
U.S. Cl.
CPC ...
A61K 38/10 (2013.01); A61K 38/05 (2013.01); A61K 38/06 (2013.01); A61K 38/07 (2013.01); A61K 38/08 (2013.01); A61P 31/04 (2018.01); A61P 31/12 (2018.01);
Abstract

A method is provided for treating a subject for a viral infection. The method includes diagnosing the subject as having a viral infection, and administering a pharmaceutically effective amount of a pharmaceutical composition to the subject. The pharmaceutical composition includes a poly-N-substituted glycine compound of a formula wherein A is a terminal N-alkyl substituted glycine residue; n is an integer; B is selected from the group consisting of NH, one and two N-substituted glycine residues, and wherein said one and two N-substituted glycine residues have N-substituents which are independently selected from natural α-amino acid side chain moieties, isomers and carbon homologs thereof; X, Y and Z are independently selected from the group consisting of N-substituted glycine residues, wherein said N-substituents are independently selected from the group consisting of natural α-amino acid side chain moieties, isomers and carbon homologs thereof, and proline residues. In some embodiments, at least one of A, B, X, Y and Z contains a halogen-bearing moiety.


Find Patent Forward Citations

Loading…